About
Professor Serfaty is an experienced and empathic clinician with over 35 years’ practice. He is one of the few dual trained consultants (psychiatrist and an accredited cognitive behavioural therapy (CBT) psychotherapist), with expertise in both psychological and pharmacological treatments.
For academic details see (https://orcid.org/0000-0001-8388-0776) and (https://profiles.ucl.ac.uk/6511-marc-serfaty/about)
Position at Priory
Professor Serfaty has been a consultant psychiatrist at Priory Hospital North London since 1996 and also holds a number of honorary consultant contracts at a range of NHS Trusts in North London as part of his role as a clinical academic at University College London (UCL).
Training
- Professor Serfaty completed an intercalated BSc (Hons) in Medical Sciences (Physiology) at St Andrews University (1978-1982).
- He achieved at least a merit or distinction in every exam taken. His clinical training (MBChB) was at Manchester University (1982-1985), working as a houseman and then as a lecturer in anatomy for a year.
- He started trained in Psychiatry at Edinburgh University, as a rotational registrar (1987-1991), completing a Master of Philosophy (MPhil) degree, investigating benzodiazepine suicides and parasuicides.
- He worked as a senior registrar and lecturer in psychiatry at the University of Newcastle-upon-Tyne (1991-1996), and also trained as a CBT therapist at the Newcastle Cognitive Therapy Centre, coming first in his year and obtaining a distinction (CertCBT).
- He is accredited in CBT and a fellow of the British Association for Cognitive and Behavioural Psychotherapies (FBABCP). While he was a senior lecturer at UCL (1996-2013) he completed a Doctorate (MD Res) titled: “The use of melatonin for sleep disturbance in depression and dementia.”
- He is a qualified university teacher, and a fellow of the Higher Education Academy (FHEA). In 2018, Marc Serfaty was promoted to professor of psychotherapy research, and also continues to work as a consultant psychiatrist.
- Professor Serfaty has over 37 years of experience working as a psychiatrist. His current clinical post is at Priory Hospital North London, and an independent health care organisation is funding his Professorship at UCL.
- He has ensured that Priory Hospital North London is a teaching hospital, linked to UCL.
- He is lead consultant for day care and supervises CBT therapists and psychology students in their practice. He is a Fellow of the Royal College of Psychiatrists (FRCPsych).
- He is recognised under section 12 of the Mental Health Act, by the secretary of state as an approved clinician and is also on the GMC register as specialist in psychiatry.
- He has extensively contributed to both undergraduate and postgraduate medical training and is an examiner for UCL and is a joint collaborator in running the depression and anxiety module in UCL’s MSc in Psychiatry.
Research Interests
Professor Serfaty is a general psychiatrist, and a specialist in CBT and related therapies, including a third wave CBT called acceptance and commitment therapy (ACT). He is interested in helping and testing people from marginalised populations, including older people, cancer patients, people with eating disorders, people with a learning disability, people with body dysmorphic disorder (BDD), older victims of crime, and more recently, victims of hate crime. He is interested in the emerging evidence for ACT, which helps people engage in things that are important to them and face their fears.
Professor Serfaty has conducted and/or collaborated in a range of randomised controlled trials (RCTs).
He has conducted a trial of ACT in people with advanced cancer, and has engaged in research on ACT in people with motor neurone disease (MND) and an ongoing trial of ACT for older people with treatment-resistant anxiety disorder.
Professor Serfaty has conducted novel and pioneering work through RCTs. These include trials of talking therapies:
- CBT for anorexia nervosa, informing National Institute for Health and Care Excellence (NICE) guidelines. Results: dietary advice alone is not beneficial.
- CBT by email for bulimia nervosa and binge eating disorder (BED). Results: email helps with engagement
- CBT versus aromatherapy massage for depression and anxiety in cancer. Results: CBT appears promising and suggests a benefit for both interventions
- CBT for depression in older people. Results: individual CBT effective, dispelling the prejudice that ‘you cannot teach an old dog new tricks’. Improvement was not due to common factors in therapy, but rather specific CBT techniques
- Helping Aged Victims of Crime (HAVoC), the impact of crime (trauma) in older people may benefit from a CBT-based Victim Improvement Package (VIP). More recent work, however, was interrupted by the pandemic and further research is required
- CBT for anxiety and depression in intellectual difficulties. Results: CBT appears promising
- CBT for depression in advanced cancer, delivered through improving access to psychological therapies (IAPT) may not be effective treatment
- CanTalk: A national UK study investigating the clinical and cost effectiveness of CBT in people with advanced cancer and depression. This did not find a benefit of CBT in this group
- CanACT: A pilot trial of ACT in people with cancer in palliative care. This suggested that giving people space to talk or ACT may be useful
- An RCT of acceptance and commitment therapy for people with MND (COMMEND) found that this was helpful with respect to the individual’s function and also with measures of mental health
- Preliminary work suggested a benefit for ACT in older people with generalised anxiety disorder (GAD) – FACTOID study. We are now conducting a fully powered trial of ACT for older people with treatment-resistant GAD (CONTACT-GAD trial)
Professor Serfaty has also been involved in a number of RCTs testing pharmacological agents. Some have been placebo controlled and others compared pharmacological agents against talking therapies:
- Professor Serfaty's interest in chronobiology, through his doctoral work, investigated the use of melatonin for sleep disturbance in dementia and depression respectively. Melatonin appeared to show a trend towards benefit with respect to depressive symptoms in people with depression, but it was not helpful in controlling the sleep-wake cycle in people with dementia
- Triple chronotherapy for a rapid response for people with depression. This pilot study suggested a benefit and calls for more research
- Trial of sertraline versus CBT for GAD (ToSCA study) showed it was difficult to recruit people as they often did not wish to take medication. However, we hope to, in part, see whether ACT is useful for treatment-resistant GAD in older people (see above)
- The ADePT trial was a trial of antidepressants in Parkinson's disease (ADepT-PD), comparing escitalopram and nortriptyline for depressive symptoms. Unfortunately, it needed to be abandoned because of recruitment problems imposed by COVID-19.
Professor Serfaty has led on the development of a number of treatment manuals:
- CBT for anorexia nervosa
- CBT for people with intellectual difficulties (Hassiotis et al)
- CBT for older victims of crime (Serfaty et al)
- ACT for people with advanced cancer (Serfaty)
- Talking control manuals for older people with depression (Serfaty)
- Talking control for people with advanced cancer (Serfaty et al)
- CBT for people with advanced cancer (Moorey and Serfaty)
- ACT for people with MND (Gould et al)
- ACT for treatment-resistant GAD in older people (Gould et al)
- Professor Serfaty is also developing a manual for the treatment of hate crime
Professor Serfaty has also been involved in research on scale development. These include scales to measure stigma in mental illness, the development of a cosmetic screening questionnaire for people with BDD and measures of safety seeking behaviours in older victims of crime.
Professor Serfaty has also contributed to a number of systematic reviews and meta-analyses, including determining the use of light therapy in depression, whether antidepressants are helpful in chronic pain, the impact of crime and interventions used in older victims of crime, the interventions used in victims of crime in people of all ages, and the impact and treatment of hate crime.
Professor Serfaty and his team have also conducted qualitative work on stigma and mental illness, the experience of talking therapies in cancer, intellectual difficulties, experiential avoidance in cancer, people’s experience of ACT as a therapy in both cancer and treatment-resistant GAD, their experience of being a victim of crime, and their experience of being a victim of hate crime.
Links to clinical articles/research papers:
2024
Serfaty M, Billings J, Vickerstaff V, Lee T, Buszewicz M, et al. (2024) Help-seeking in older crime victims: A mixed-methods study in collaboration with the Metropolitan Police Service. PLOS Mental Health 1(3): e0000082. https://doi.org/10.1371/journal.pmen.0000082
West G, Satchell J, Ford P, Serfaty M, (2024) ‘It’s not like you’re delivering Amazon packages’: A qualitative study and thematic analysis exploring older victims’ perspectives on how the police responded to their crime report, Policing: A Journal of Policy and Practice, Volume 18,paae042, https://doi.org/10.1093/police/paae042
Schrag A, Carroll C, Duncan G, Molloy S, Grover L, Hunter R, Brown R, Freemantle N, Whipps J, Serfaty MA, Lewis G. Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease. BMC Neurol. 2022 Dec 12;22(1):474. doi: 10.1186/s12883-022-02988-5. PMCID: PMC9743717.
Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA, Graham CD, McCracken LM, Goldstein LH, Al-Chalabi A, Orrell RW, Williams T, Noad R, Baker I, Faull C, Lambert T, Chhetri SK, Ealing J, Hanratty A, Radunovic A, Gunawardana N, Meadows G, Gorrie GH, Young T, Lawrence V, Cooper C, Shaw PJ, Howard RJ; COMMEND Collaboration Group. Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK. Lancet. 2024 Jun 1;403(10442):2381-2394. doi: 10.1016/S0140-6736(24)00533-6. Epub 2024 May 9. PMID: 38735299.
Birkinshaw H, Friedrich C, Cole P, Eccleston C, Serfaty M, Stewart G, et al. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Health Technol Assess2024;28(62) https://doi.org/10.3310/MKRT2948
Birkinshaw H, Friedrich CM, Cole P, Eccleston C, Serfaty M, Stewart G, White S, Moore RA, Phillippo D, Pincus T. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database Syst Rev. 2023 May 10;5(5):CD014682. doi:10.1002/14651858. CD014682.pub2. PMID: 37160297; PMCID: PMC10169288. Accessed 11 October 2024.
2023
Satchell, J., Dalrymple, N., Leavey, G., & Serfaty, M. (2023). “If we don't forgive, it's like holding on to them”: A qualitative study of religious and spiritual coping on psychological recovery in older crime victims. Psychological Trauma: Theory, Research, Practice, and Policy. Advance online publication. https://doi.org/10.1037/tra0001420
COMMEND Collaboration Group, Gould, R. L., Rawlinson, C., Thompson, B., Weeks, K., Gossage-Worrall, R., Cantrill, H., Serfaty, M. A., Graham, C. D., McCracken, L. M., White, D., Howard, R. J., Bursnall, M., Bradburn, M., Al-Chalabi, A., Orrell, R., Chhetri, S. K., Noad, R., Radunovic, A., ... McDermott, C. J. (2023). Acceptance and commitment therapy for people living with motor neuron disease: an uncontrolled feasibility study. Pilot and Feasibility Studies, 9(1), Article 116. https://doi.org/10.1186/s40814-023-01354-7
Gould, R., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., . . . McDermott, C. J. (2023). A randomised controlled trial of Acceptance and Commitment Therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): Study protocol. BMC Neurol 22, 431 (2022). https://doi.org/10.1186/s12883-022-02950-5
2022
Schrag A, Carroll C, Duncan G, Molloy S, Grover L, Hunter R, Brown R, Freemantle N, Whipps J, Serfaty MA, Lewis G. Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease. BMC Neurol. 2022 Dec 12;22(1):474. doi: 10.1186/s12883-022-02988-5. PMID: 36510237; PMCID: PMC9743717.
Satchell, J., Craston, T., Drennan, V. M., Billings, J., & Serfaty, M. (2022). Psychological Distress and Interventions for Older Victims of Crime: A Systematic Review. Trauma, Violence, & Abuse, 0(0). https://doi.org/10.1177/15248380221130354
Davis, S., Serfaty, M., Low, J. et al. Experiential Avoidance in Advanced Cancer: a Mixed-Methods Systematic Review. Int.J. Behav. Med. (2022). https://doi.org/10.1007/s12529-022-10131-4
Serfaty M., Broadway-Horner, M., Hassiotis A (2022) The Application of CBT for Adults with Learning Disabilities. Chapter 24, pages 507-533 in Evidence-based Treatment for Anxiety Disorders and Depression: A Cognitive Behavioural Compendium, Cambridge University Press 2022
Lamirel, D., Davis, S., Low, J. Serfaty, M.A., Armstrong M Talking control sessions in people with advanced cancer: a qualitative analysis of sessions. BMC Psychol 10, 126 (2022). https://doi.org/10.1186/s40359-022-00837-1
2021
Birkinshaw H, Friedrich C, Cole P, Eccleston C, Serfaty M, Stewart G, White S, Moore RA, Pincus T. Antidepressants for pain management in adults with chronic pain: a network meta‐analysis. Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No.: CD014682. DOI: 10.1002/14651858.CD014682. Accessed 09 November 2022.
Veale D, Serfaty M, Humpston C, Papageorgiou A, Markham S, Hodsoll J et al. (2021) Out-patient triple chronotherapy for the rapid treatment and maintenance of response in depression: feasibility and pilot randomised controlled trial. BJPsych Open. 2021 Nov 24;7(6). e220. https://doi.org/10.1192/bjo.2021.1044
Aspden T, Armstrong M, Serfaty M. Views of healthcare professionals on recruiting to a psychosocial randomised controlled trial: a qualitative study. BMC Health Serv Res. 2021 Aug 18;21(1):837. doi: 10.1186/s12913-021-06817-2. PMID: 34407826; PMCID: PMC8371878.
Gould, R; Loebach Wetherell, J; Serfaty, M; Kimona, K; Lawrence, V; Jones, R; Livingston, G; ... Howard, R; + view all (2021) A feasibility study of Acceptance and Commitment Therapy for older people with treatment-resistant generalised anxiety disorder (FACTOID). Health Technology Assessment , 25 (54) 10.3310/hta25540.
Gould, R. L., Wetherell, J. L., Kimona, K., Serfaty, M., Jones, R., Graham, C., & Howard, R. J. (2021). Acceptance and Commitment Therapy for late-life treatment-resistant generalised anxiety disorder: A feasibility study. Age and Ageing. https://doi.org/10.1093/ageing/afab059
2020
Serfaty M, Aspden T, Satchell J, Kessel A, Laycock G, Brewin C R, Buszewicz M, O'Keeffe A, Hunter R, Leavey G, Cuming-Higgs J, Drennan V, Riveros M, Andrew D, Blanchard M. (2020). The clinical and cost effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (The VIP trial): study protocol for a randomised controlled trial. Trials. DOI : 10.1186/s13063-020-4211-9
Serfaty, M., Shafran, R., Vickerstaff, V., Aspden, T. (2020) A pragmatic approach to measuring adherence in treatment delivery in psychotherapy. Cognitive Behaviour Therapy. d.o.i: 10.1080/16506073.2020.1717594
Humpston, C., Benedetti, F., Serfaty, M., Markham, S., Hodsoll, J., Young, A. H., & Veale, D. (2020). Chronotherapy for the rapid treatment of depression: A meta-analysis. Journal of Affective Disorders, 261, 91-102. doi:10.1016/j.jad.2019.09.078
2019
Weeks, K., Gould, R., McDermott, C., Lynch, J., Goldstein, L., Graham, C., Lawrence, V. (2019). Needs and preferences for psychological interventions of people with motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(7-8), https://doi.org/10.1080/21678421.2019.1621344
Serfaty M, Armstrong M, Vickerstaff V, Davis S, Gola A, McNamee P, Omar RZ, King M, Tookman A, Jones L, Low JTS. Acceptance and commitment therapy for adults with advanced cancer (CanACT): A feasibility randomised controlled trial. Psychooncology. 2019 Mar;28(3):488-496. doi: 10.1002/pon.4960. Epub 2018 Dec 21. PMID: 30511788.
Serfaty, M., King, M., Nazareth, I., Moorey, S., Aspden, T., Mannix, K., Jones, L. (2019). Effectiveness of cognitive-behavioural therapy for depression in advanced cancer: CanTalk randomised controlled trial.. Br J Psychiatry, 1-9. doi:10.1192/bjp.2019.207
Lawrence, V., Kimona, K., Howard, R., Serfaty, M., Wetherell, J., Livingston, G., . . . Gould, R. (2019). Optimising the acceptability and feasibility of Acceptance and Commitment Therapy for treatment-resistant generalised anxiety disorder in older adults. Age and Ageing 48(5), 741–750. https://doi.org/10.1093/ageing/afz082
Gallagher, P. (2019). Older crime victims remain depressed and anxious for months after incident. Retrieved from https://inews.co.uk/news/health/old-crime-victims-depressed-anxious-trial-study-ucl/
Serfaty, M., King, M., Nazareth, I., Moorey, S., Aspen, T., Tookman, A., . . . JONES, L. (2019). Manualised cognitive–behavioural therapy in treating depression in advanced cancer: the CanTalk RCT. doi:10.3310/hta23190 https://inews.co.uk/news/health/old-crime-victims-depressed-anxious-trial-study-ucl/ Older crime victims remain depressed and anxious for months after incident; i newspaper. Wednesday August 14th 2019.
Davis S, Low J, Lanceley A, Serfaty M 630 Experiential avoidance in advanced cancer: patients’ and therapists’ perspectives. Journal of Psychosocial Oncology Research and Practice: September 2019 - Volume 1 - Issue 1S - p e10 https://app.oxfordabstracts.com/events/829/program-app/submission/128052.
Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Mannix K, Davis S, Wood J, Jones L. (2019) Effectiveness of CBT for depression in advanced cancer; the CanTalk Randomised Controlled Trial. British Journal of Psychiatry (2019). doi: 10.1192/bjp.2019.207
Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, et al. (2019) Manualised cognitive behavioural therapy in treating depression in advanced cancer: the CanTalk RCT. Health Technol Assess 2019;23(19)
2018
Hassan S, Bennet K, Serfaty M (2018) Delivering cognitive behavioural therapy to advanced cancer patients: A qualitative exploration into therapists' experiences within a UK psychological service. Clin Psychol Psychother. 2018;1–10. DOI: 10.1002/cpp.2190
2017
Hassiotis, A., Sheehan, R., & Serfaty, M. (2017). Psychological treatments for depression in adults with mild to moderate intellectual disabilities: are we there yet?. The Lancet Psychiatry. doi:10.1016/S2215-0366(17)30431-5
Buszewicz M, Cape J, Serfaty M, Shafran R, Kabir T, Tyrer P, et al. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines. Health Technol Assess 2017;21(45).
2016
Low J, Serfaty M, Davis S, Vickerstaff V, Gola A, Omar RZ, King M, Tookman A, Austen JS, Turner K, Jones L. Acceptance and commitment therapy for adults with advanced cancer (CanACT): study protocol for a feasibility randomised controlled trial. Trials. 2016 Feb 11;17(1):77. doi: 10.1186/s13063-016-1169-8.
Serfaty MA, King M, Nazareth I, Tookman A, Wood J, Gola A, Aspden T, Mannix K, Davis S, Moorey S, Jones L (2016) The clinical and cost effectiveness of CBT plus treatment as usual for the treatment of depression in advanced cancer: a randomised controlled trial (CanTalk). Trials. 17,113. doi: 10.1186/s13063-016-1223-6
2015
Serfaty MA, Ridgewell A, Drennan V, Kessel A, Brewin CR, Wright A, Laycock G, Blanchard A (2015) Helping Aged Victims of Crime (the HAVoC study); Common crime, older people and mental illness. Behavioural and Cognitive Psychotherapy. 1-16. doi:10.1017/S1352465814000514
2013
Serfaty, M., Ohlin, S. and Blanchard, M. (2013). Victim Improvement Package (VIP): a manual of cognitive behaviour therapy for Helping Aged Victims of Crime (HAVoC) with anxiety, depression and post-traumatic stress. Copyright Camden and Islington Foundation Trust (CIFT) and University College London.
Hassiotis A, Serfaty M, Azam K, Strydom A, Blizard R, Romeo R, Martin S, King M (2013) Manualised Individual Cognitive Behavioural Therapy for mood disorders in people with mild to moderate intellectual disability: a feasibility randomised controlled trial. Journal of Affective Disorders. Jul 1. pii: S0165-0327(13)00455-2. doi: 10.1016/j.jad.2013.05.076.
Moorey S and Serfaty M (2013) Cascading to IAPT; the CanTalk trial 41st BABCP annual conference, 19th July, 2013.
2012
Serfaty MA, Raven PW (2012). Could melatonin be a more suitable alternative to synthetic melatonin agonists? Lancet, 379, 217 - 217.
Veale D, Ellison N, Werner TG, Dodhia R, Serfaty MA, Clarke A (2011). Development of a Cosmetic Procedure Screening Questionnaire (COPS) for Body Dysmorphic Disorder. J Plast Reconstr Aesthet Surg. 2012 Apr;65(4):530-2. doi: 10.1016/j.bjps.2011.09.007. Epub 2011 Oct 15. PMID: 22000332.
Azam K, Serfaty M, King M, Martin S, Strydom A, Parkes C, Hassiotis A (2012). The development of manualised cognitive behaviour treatment for adults with mild intellectual disability and common mental disorders. Psychiatrike, 23, 109-116.
Hassiotis, A., Serfaty, M., Azam, K., Martin, S., Strydom, A., & King, M. (2012). A Manual of Cognitive Behaviour Therapy for People with Mild Learning Disabilities and Common Mental Disorders: A training guide to help professional therapists in treating people with communication and cognitive problems in CBT. Camden & Islington NHS Foundation Trust and University College London, 2012.
2011
Hassiotis A, Serfaty M, Azam M, Strydom M, King M, Martin S, Parkes C, Blizard R (2011) Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a pilot randomised controlled trial. Trials 2011, 12:95 doi:10.1186/1745-6215-12-95.
Serfaty M, Csipke E, Deborah Haworth D, Murad S, King M (2011) A Talking Control for use in evaluating effectiveness of Cognitive Behavioral Therapy. Behavior Research and Therapy. 49, 433-440. https://doi.org/10.1016/j.brat.2011.05.005
Holman AJ, Serfaty MA, Leurent BE, King MB (2011). Cost-effectiveness of cognitive behaviour therapy versus talking and usual care for depressed older people in primary care. BMC Health Serv Res, 11, 33 - . doi:10.1186/1472-6963-11-33
Low J, Davis S, Drake R, King M, Tookman A, Turner K, Serfaty M, Leurent B, Jones L (2011). The role of acceptance in rehabilitation in life threatening illness. Journal of Pain and Symptom Management, 43(1), 20-28.
Serfaty M, Wilkinson S, Mannix K, Freeman C, King MB (2011). ) The ToT Study: Helping with Touch or Talk (ToT ): a pilot randomised controlled trial to examine the clinical effectiveness of aromatherapy massage versus cognitive behaviour therapy for emotional distress in patients in cancer/palliative care. Psycho-oncology,21, 563-569.
2010
Holt, S., Serfaty, M. (2010) Larger studies of melatonin for depression/sleep needed. Focus on Alternative and Complementary Therapies, 15: 317–318. doi: 10.1111/j.2042-7166.2010.01057_18.x
Serfaty MA, Osborn D, Buszewicz MJ, Blizard R and Raven PW (2010) A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. International Clinical Psychopharmacology, 25(3): 132-142
2009
Serfaty MA, Haworth D, Blanchard M, Buszewicz M, Murad S, King M. (2009) Clinical effectiveness of cognitive behaviour therapy, versus control treatment or treatment as usual for depressed older people in general practice. Archives of General Psychiatry; 66(12):1332-40. doi:10.1001/archgenpsychiatry.2009.165
2008
Blanchard M, Serfaty M, Duckett S, Flatley S (2008) Adapting services for a changing society: a reintegrative model for old age psychiatry (based on a model proposed by Knight and Emanuel, 2007). Int J Geriatr Psychiatr 24, ( 2), 202-206.
2007
M B King , S Dinos , M Serfaty , S Weich , S Stevens (2007) Authors reply: Br J Psychiatry. 2007 Oct ;191 :364 17906264.
PH Robinson, MA Serfaty (2007) Getting better byte by byte: a pilot randomised controlled trial of email therapy for bulimia nervosa and binge eating disorder. European Eating Disorders Review, Epub ahead of print.
M King , S Dinos , J Shaw , R Watson , S Stevens , F Passetti , S Weich , M Serfaty (2007) The Stigma Scale: development of a standardised measure of the stigma of mental illness. Br J Psychiatry. 2007 Mar ;190 :248-54
2006
M A Serfaty M A (2006) MD thesis: The Use of melatonin in depression and dementia, University of London.
E Csipke, M Serfaty, M Buszewicz (2006) Optimising recruitment from primary care: methods of recruiting depressed older adults. Optimizing recruitment from primary care: methods pf recruiting older people with depression. Primary Health Care Research and Development, 7; 1-8.
2004
J Warner, N Pitts, M J Crawford, M Serfaty, P Prabhakaran, R Amin (2004) Sexual activity among patients in psychiatric hospital wards- a cross sectional survey. Journal of the Royal Society of Medicine,97 (10), 477-9.
S Dinos, S Stevens, M Serfaty, S Weich and M King (2004) Stigma: the feelings and experiences of 46 people with mental illness. A qualitative study. British Journal of Psychiatry, 184, 176 – 181.
2003
M.A. Serfaty, D Osborne, M.J. Buszewicz, and P.W. Raven (2003) The Effect of Exogeneous Melatonin in Major Depression. Chronobiology International, 20, 1191-2.
Robinson P and Serfaty MA (2003) Computers, email and therapy in eating disorders. European Eating Disorders Review. 11, 210-221.
McKenzie K, Serfaty M, Crawford M (2003) Suicide in ethnic minority groups. British Journal of Psychiatry, 183, 100-102.
2002
Serfaty MA, Kennell-Webb S, Warner J, Blizard R, Raven P (2002) Double blind randomised placebo controlled trial of low dose melatonin for sleep disorder in dementia. International Journal of Geriatric Psychiatry, 17: 1-8.
Serfaty MA, Bothwell R, Marsh R, Ashton H, Blizard R, Scott J (2002) Event related potentials and cognitive processing of affectively toned words in depression. Journal of Psychophysiology, 16:56-66.
2001
Robinson PH, Serfaty MA (2001) The use of e-mail in the identification of bulimia nervosa and its treatment. European Eating Disorders Review, 9, 182-193
1999
Serfaty, M. A., Turkington, D., Heap M., Ledsham, L. and Jolley,E. (1999) Cognitive Therapy versus dietary counselling in the outpatient treatment of anorexia nervosa: effects of the treatment phase. European Eating Disorders Review 7(1), 334-350.
1998
Serfaty M and McCluskey S (1998) Compulsory Treatment of anorexia nervosa and the moribund patient. European Eating Disorders Review 6(1), 27-37.
1997
Serfaty M A, Lawrie A, Smith B, Brind A M, Watson J P, Gilvarry E andBassendine MF (1997), Risk factors and medical follow up of drug users tested for hepatitis C - Can the risk of transmission be reduced? Drug and Alcohol Review, 16, 33-347.
1996
Serfaty M A, Martin L M, Lingham R and Ferrier I N (1996) The effect of psychotropic medication on seizure duration during bilateral electroconvulsive therapy: a retrospective study. Journal of Psychopharmacology, 10(4), 303-308.
1995
Lawrie, A., Serfaty, M.A., Smith, C. (1995) Is residential Psychiatric on call justified?, Psychiatric Bulletin,20(1), 12-14.
Serfaty, M.A., McCluskey, S., Eccleston, D. (1995) A case of extreme suicidality following serotonin syndrome. British Journal of Psychiatry, 167, 410.
1993
Serfaty M. and Masterton G. (1993) Fatal Poisonings Attributed to Benzodiazepines in Britain during the 1980's. British Journal of Psychiatry, 163, 386 - 393.
Books/other publications
- Serfaty M, Broadway-Horner M, Hassiotis A. The Application of CBT for Adults with Learning Disabilities. In: Todd G, Branch R, eds. Evidence-Based Treatment for Anxiety Disorders and Depression: A Cognitive Behavioral Therapy Compendium. Cambridge University Press; 2022:507-532.
- Serfaty, M., Ohlin, S., Blanchard M. (2013). Victim Improvement Package (VIP): A manual of cognitive behaviour therapy for Helping Aged Victims of Crime (HAVoC) with anxiety, depression and post-traumatic stress. (Therapists’ version). London: University College London and Camden and Islington NHS Foundation Trust.
- Cognitive Behaviour Psychotherapy, (2000) Marc Serfaty and David Clark, in Psychotherapy, 3rd Edition, Harold Maxwell, Editor.
Languages
- Fluent French
- Working knowledge of Russian